Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)

Recruiting phase 2 trial using ctDNA testing to decide when to start routine treatment in people with HPV-associated malignancies (planned n=30). Brief title verified via ClinicalTrials.gov API v2 on 13 Nov 2026.

Memorial Sloan Kettering Cancer Center